This activity addressed the complexity of managing patients with obesity who require anticoagulation, with a particular focus on the use of direct oral anticoagulants (DOACs). As obesity has become increasingly common, how to best treat these patients with anticoagulation is a frequently encountered clinical question. In this program, speakers from several subspecialties (endocrinology, cardiology, hematology, and bariatric surgery) reviewed the current medical literature on DOAC use in patients with obesity and provide their unique perspectives to address this question. The activity concluded with a case-based debate and Q&A session to facilitate interdisciplinary discussion and provide insights on best management strategies.
The content of this activity was originally presented as part of a live event. .
